Coherus Oncology, Inc. (CHRS)

Coherus Oncology Revenue

Coherus Oncology had revenue of $10.25M in the quarter ending June 30, 2025, a decrease of -0.41%. This brings the company's revenue in the last twelve months to $272.21M, up 52.33% year-over-year. In the year 2024, Coherus Oncology had annual revenue of $266.96M with 3.78% growth.

• Revenue (ttm): $272.21M
• Revenue Growth: +52.33%
• P/S Ratio: 0.42
• Revenue / Employee: $1,193,899
• Employees: 228
• Market Cap: 114.58M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	266.96M	9.72M	3.78%
Dec 31, 2023	257.24M	46.20M	21.89%
Dec 31, 2022	211.04M	-115.51M	-35.37%
Dec 31, 2021	326.55M	-149.27M	-31.37%
Dec 31, 2020	475.82M	119.75M	33.63%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.